Temat: "Chemokine CCL22" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19.
Autorzy:: Korobova ZR; Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, Mira St. 14, 197101 St. Petersburg, Russia.; Department of Immunology, Pavlov First State Medical University of St. Petersburg, L'va Tolstogo St. 6-8, 197022 St. Petersburg, Russia.
Arsentieva NA; Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, Mira St. 14, 197101 St. Petersburg, Russia.; Department of Immunology, Pavlov First State Medical University of St. Petersburg, L'va Tolstogo St. 6-8, 197022 St. Petersburg, Russia.
Totolian AA; Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, Mira St. 14, 197101 St. Petersburg, Russia.; Department of Immunology, Pavlov First State Medical University of St. Petersburg, L'va Tolstogo St. 6-8, 197022 St. Petersburg, Russia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 23; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:: Journal Article
MeSH Terms:: Chemokine CCL22*
COVID-19*
Humans ; Cell Differentiation ; Health Status ; Plasma

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway.
Autorzy:: Liang H; Chemotherapy Department, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, People's Republic of China.
Peng J; Chemotherapy Department, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, People's Republic of China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Feb 17; Vol. 17 (2), pp. e0263997. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cell Movement*
Cell Proliferation*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carcinoma, Non-Small-Cell Lung/*pathology
Chemokine CCL22/*metabolism
RNA, Long Noncoding/*genetics
Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/metabolism ; Chemokine CCL22/genetics ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Neoplasm Invasiveness ; Prognosis ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A Cornflower Extract Containing N -Feruloylserotonin Reduces Inflammation in Human Skin by Neutralizing CCL17 and CCL22 and Inhibiting COX-2 and 5-LOX.
Autorzy:: Carola C; Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.
Salazar A; Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.
Rakers C; Merck Healthcare KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.
Himbert F; Greenpharma, 3 Allée du Titane, 45000 Orléans, France.
Do QT; Greenpharma, 3 Allée du Titane, 45000 Orléans, France.
Bernard P; Greenpharma, 3 Allée du Titane, 45000 Orléans, France.
von Hagen J; Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.; Pokaż więcej
Źródło:: Mediators of inflammation [Mediators Inflamm] 2021 Sep 13; Vol. 2021, pp. 6652791. Date of Electronic Publication: 2021 Sep 13 (Print Publication: 2021).
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Inflammatory Agents/*pharmacology
Chemokine CCL17/*antagonists & inhibitors
Chemokine CCL22/*antagonists & inhibitors
Cyclooxygenase 2 Inhibitors/*pharmacology
Lipoxygenase Inhibitors/*pharmacology
Plant Extracts/*pharmacology
Serotonin/*analogs & derivatives
Skin/*drug effects
Zea mays/*chemistry
Cells, Cultured ; Chemokine CCL17/chemistry ; Chemokine CCL22/chemistry ; Humans ; Molecular Docking Simulation ; Plant Extracts/analysis ; Serotonin/chemistry ; Serotonin/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Skullcapflavone II Suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT Cells.
Autorzy:: Lee H; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Department of Dermatology, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Human-Environment Interface Biology, Medical Research Center, Seoul National University, Seoul 03080, Korea.; Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.
Lee DH; Department of Dermatology, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Human-Environment Interface Biology, Medical Research Center, Seoul National University, Seoul 03080, Korea.; Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.
Oh JH; Department of Dermatology, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Human-Environment Interface Biology, Medical Research Center, Seoul National University, Seoul 03080, Korea.; Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.
Chung JH; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Department of Dermatology, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Human-Environment Interface Biology, Medical Research Center, Seoul National University, Seoul 03080, Korea.; Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jun 16; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 16.
Typ publikacji:: Journal Article
MeSH Terms:: Cathepsins/*biosynthesis
Chemokine CCL17/*biosynthesis
Chemokine CCL22/*biosynthesis
Flavonoids/*pharmacology
Interferon-gamma/*pharmacology
Tumor Necrosis Factor-alpha/*pharmacology
Cathepsins/genetics ; Cell Survival/drug effects ; Chemokine CCL17/genetics ; Chemokine CCL22/genetics ; Gene Expression Regulation/drug effects ; HaCaT Cells ; Humans ; Keratinocytes/metabolism ; NF-kappa B/metabolism ; STAT1 Transcription Factor/metabolism ; Signal Transduction ; p38 Mitogen-Activated Protein Kinases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22.
Autorzy:: Wu C; Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
Lyu A; Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
Shan S; Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.; Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.; Chen Hongduo Academician Workstation, Shaoxing Central Hospital, Shaoxing 312030, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Apr 16; Vol. 28 (8). Date of Electronic Publication: 2023 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Dermatitis, Atopic*/chemically induced
Dermatitis, Atopic*/drug therapy
Animals ; Mice ; Keratinocytes ; NF-kappa B/metabolism ; Chemokine CCL22/metabolism ; Chemokine CCL22/pharmacology ; p38 Mitogen-Activated Protein Kinases/metabolism ; Dinitrochlorobenzene/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Chemokine CCL17/metabolism ; Chemokine CCL17/pharmacology ; Chemokine CCL17/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Autorzy:: Li ZQ; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Wang HY; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Zeng QL; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Yan JY; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Hu YS; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Li H; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Yu ZJ; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2020 Jan; Vol. 9 (2), pp. 711-723. Date of Electronic Publication: 2019 Nov 25.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor/*metabolism
Carcinoma, Hepatocellular/*pathology
Chemokine CCL22/*metabolism
Hepatitis B/*complications
MicroRNAs/*genetics
T-Lymphocytes, Regulatory/*immunology
Transcription Factor RelA/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/virology ; Cell Proliferation ; Chemokine CCL22/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Hepatitis B/virology ; Hepatitis B virus ; Humans ; Liver Neoplasms/immunology ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Prognosis ; Transcription Factor RelA/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: MiR-34c-5p plays a protective role in chronic obstructive pulmonary disease via targeting CCL22 .
Autorzy:: Gao HX; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.
Su Y; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.
Zhang AL; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.
Xu JW; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.
Fu Q; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.
Yan L; a Department of Respiratory Medicine , Hebei General Hospital , Shijiazhuang , China.; Pokaż więcej
Źródło:: Experimental lung research [Exp Lung Res] 2019 Feb - Mar; Vol. 45 (1-2), pp. 1-12. Date of Electronic Publication: 2019 Apr 29.
Typ publikacji:: Journal Article
MeSH Terms:: Chemokine CCL22/*antagonists & inhibitors
MicroRNAs/*pharmacology
Pulmonary Disease, Chronic Obstructive/*drug therapy
Animals ; Bronchoalveolar Lavage Fluid/chemistry ; Chemokine CCL22/drug effects ; Disease Models, Animal ; Inflammation ; Protective Agents/pharmacology ; Pulmonary Disease, Chronic Obstructive/genetics ; Rats ; Smoke/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Potential role of tumor-associated macrophages and CD163/CD68 ratio in mycosis fungoides and Sézary syndrome in correlation with serum sCD163 and CCL22.
Autorzy:: El-Guindy DM; Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Elgarhy LH; Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Elkholy RA; Clinical Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Ali DA; Clinical Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Helal DS; Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.; Pokaż więcej
Źródło:: Journal of cutaneous pathology [J Cutan Pathol] 2022 Mar; Vol. 49 (3), pp. 261-273. Date of Electronic Publication: 2021 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Antigens, CD/*analysis
Antigens, Differentiation, Myelomonocytic/*analysis
Chemokine CCL22/*blood
Mycosis Fungoides/*pathology
Receptors, Cell Surface/*analysis
Sezary Syndrome/*pathology
Tumor-Associated Macrophages/*pathology
Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Skin/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2.
Autorzy:: Meister S; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Hahn L; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Beyer S; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Mannewitz M; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Perleberg C; Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, University Hospital, LMU Munich, 81377 Munich, Germany.
Schnell K; Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, University Hospital, LMU Munich, 81377 Munich, Germany.
Anz D; Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, University Hospital, LMU Munich, 81377 Munich, Germany.
Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Schmoeckel E; Department of Pathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Mayr D; Department of Pathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Hasbargen U; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Zati Zehni A; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Mahner S; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Jeschke U; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; Department of Gynecology and Obstetrics, University Hospital Augsburg, 86156 Augsburg, Germany.
Kolben T; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 07; Vol. 23 (3). Date of Electronic Publication: 2022 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Down-Regulation*
Decidua/*immunology
Galectin 2/*metabolism
Pre-Eclampsia/*metabolism
T-Lymphocytes, Regulatory/*cytology
Adolescent ; Adult ; Apoptosis ; Case-Control Studies ; Cells, Cultured ; Chemokine CCL22/metabolism ; Female ; Forkhead Transcription Factors/metabolism ; Humans ; Maternal Age ; Pregnancy ; T-Lymphocytes, Regulatory/metabolism ; Up-Regulation ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.
Autorzy:: Jorapur A; Discovery Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Marshall LA; Quantitative Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Jacobson S; Discovery Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Xu M; Computational Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Marubayashi S; Discovery Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Zibinsky M; Drug Discovery, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Hu DX; Drug Discovery, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Robles O; Drug Discovery, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Jackson JJ; Drug Discovery, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Baloche V; CNRS-UMR 8126, Gustave Roussy and Paris-Sud/Paris-Saclay University, Villejuif, France.
Busson P; CNRS-UMR 8126, Gustave Roussy and Paris-Sud/Paris-Saclay University, Villejuif, France.
Wustrow D; Drug Discovery, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Brockstedt DG; Discovery Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Talay O; Discovery Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Kassner PD; Quantitative Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.
Cutler G; Computational Biology, RAPT Therapeutics, Inc., South San Francisco, California, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2022 Jan 13; Vol. 18 (1), pp. e1010200. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Chemokine CCL17/*immunology
Chemokine CCL22/*immunology
Epstein-Barr Virus Infections/*immunology
Neoplasms/*immunology
Neoplasms/*virology
T-Lymphocytes, Regulatory/*immunology
Animals ; Epstein-Barr Virus Infections/complications ; Herpesvirus 4, Human ; Heterografts ; Hodgkin Disease/immunology ; Hodgkin Disease/virology ; Humans ; Mice ; Nasopharyngeal Carcinoma/immunology ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/immunology ; Nasopharyngeal Neoplasms/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
Autorzy:: Scheu S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, 40225 Düsseldorf, Germany. .
Ali S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, 40225 Düsseldorf, Germany. .
Ruland C; Department of Psychiatry, University of Münster, 48149 Münster, Germany. .; Cells in Motion, Cluster of Excellence, University of Münster, 48149 Münster, Germany. .
Arolt V; Department of Psychiatry, University of Münster, 48149 Münster, Germany. .
Alferink J; Department of Psychiatry, University of Münster, 48149 Münster, Germany. .; Cells in Motion, Cluster of Excellence, University of Münster, 48149 Münster, Germany. .; Department of Psychiatry, Alexian Brothers Hospital, 48149 Münster, Germany. .; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2017 Nov 02; Vol. 18 (11). Date of Electronic Publication: 2017 Nov 02.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Autoimmunity*/immunology
Autoimmune Diseases of the Nervous System/*immunology
Chemokine CCL17/*immunology
Chemokine CCL22/*immunology
Receptors, CCR4/*immunology
Animals ; Autoimmune Diseases of the Nervous System/drug therapy ; Autoimmune Diseases of the Nervous System/pathology ; Central Nervous System/drug effects ; Central Nervous System/immunology ; Central Nervous System/pathology ; Chemokine CCL17/analysis ; Chemokine CCL22/analysis ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Dendritic Cells/pathology ; Encephalomyelitis, Autoimmune, Experimental/drug therapy ; Encephalomyelitis, Autoimmune, Experimental/immunology ; Encephalomyelitis, Autoimmune, Experimental/pathology ; Humans ; Molecular Targeted Therapy/methods ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/immunology ; Multiple Sclerosis/pathology ; Receptors, CCR4/analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Individuals co-exposed to sand fly saliva and filarial parasites exhibit altered monocyte function.
Autorzy:: Sangare M; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada.
Coulibaly YI; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.; Dermatology Hospital of Bamako, Bamako, Mali.
Huda N; Department of Pediatrics, University of California, San Francisco, California, United States of America.
Vidal S; Institut Recerca H. Sant Pau C. Sant Quintí, Spain.
Tariq S; Laboratory of Parasitic Diseases, LPD, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Coulibaly ME; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Coulibaly SY; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Soumaoro L; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Dicko I; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Traore B; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.; Dermatology Hospital of Bamako, Bamako, Mali.
Sissoko IM; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Traore SF; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Faye O; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.; Dermatology Hospital of Bamako, Bamako, Mali.
Nutman TB; Laboratory of Parasitic Diseases, LPD, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Valenzuela JG; Vector Molecular Biology Section, LMVR, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Oliveira F; Vector Molecular Biology Section, LMVR, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Doumbia S; Mali International Center for Excellence in Research, Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Kamhawi S; Vector Molecular Biology Section, LMVR, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Semnani RT; Autoimmunity and Translational Immunology, Precigen, Inc. A wholly owned subsidiary of Intrexon Corporation, Germantown, Maryland, United States of America.; Pokaż więcej
Źródło:: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Jun 09; Vol. 15 (6), pp. e0009448. Date of Electronic Publication: 2021 Jun 09 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:: Brugia malayi/*immunology
Insect Proteins/*immunology
Monocytes/*parasitology
Phlebotomus/*immunology
Saliva/*immunology
Adaptive Immunity ; Animals ; Cells, Cultured ; Chemokine CCL22/genetics ; Chemokine CCL22/metabolism ; Coinfection ; Endemic Diseases ; Filariasis/complications ; Filariasis/immunology ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/immunology ; Immunity, Cellular ; Leishmaniasis, Cutaneous/complications ; Leishmaniasis, Cutaneous/immunology ; Lipopolysaccharides/toxicity ; Mali ; Monocytes/physiology ; RNA, Messenger ; Recombinant Proteins ; Salivary Glands ; T-Lymphocytes, Helper-Inducer

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Autorzy:: Li X; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
Liu Z; Department of Oral and Maxillofacial & Head and Neck, Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People's Republic of China.; National Center for stomatology, National Clinical Research Center For Oral diseases, Shanghai Key Laboratory of Stomatology, Shanghai, 200011, People's Republic of China.
Zhou W; Department of Oral and Maxillofacial & Head and Neck, Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People's Republic of China.; National Center for stomatology, National Clinical Research Center For Oral diseases, Shanghai Key Laboratory of Stomatology, Shanghai, 200011, People's Republic of China.
Liu X; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. .
Cao W; Department of Oral and Maxillofacial & Head and Neck, Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People's Republic of China. .; National Center for stomatology, National Clinical Research Center For Oral diseases, Shanghai Key Laboratory of Stomatology, Shanghai, 200011, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Aug 15; Vol. 21 (1), pp. 922. Date of Electronic Publication: 2021 Aug 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell/*etiology
Carcinoma, Squamous Cell/*metabolism
Chemokine CCL22/*genetics
Mouth Neoplasms/*etiology
Mouth Neoplasms/*metabolism
Receptor, Notch1/*genetics
Th2 Cells/*immunology
Th2 Cells/*metabolism
Adult ; Aged ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Chemotaxis, Leukocyte/genetics ; Chemotaxis, Leukocyte/immunology ; Computational Biology/methods ; Female ; GATA3 Transcription Factor/genetics ; GATA3 Transcription Factor/metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Lymphocyte Count ; Lymphocytes, Tumor-Infiltrating ; Male ; Middle Aged ; Mouth Floor/metabolism ; Mouth Floor/pathology ; Mouth Neoplasms/mortality ; Mouth Neoplasms/pathology ; Mutation ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.
Autorzy:: Sun J; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.; Laboratory of Neuromuscular Disorders and Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Sun J; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Song B; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Zhang L; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Shao Q; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Liu Y; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Yuan D; Key Laboratory of Precision Biomedicine, Institute of Zhongyuan Biomedical Sciences, Liaocheng People's hospital, Liaocheng, 252000, Shandong, P. R. China.
Zhang Y; The Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.
Qu X; Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.; Key Laboratory of Precision Biomedicine, Institute of Zhongyuan Biomedical Sciences, Liaocheng People's hospital, Liaocheng, 252000, Shandong, P. R. China.; The Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, P. R. China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2016 Oct 24; Vol. 6, pp. 35855. Date of Electronic Publication: 2016 Oct 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*pharmacology
Chemokine CCL22/*metabolism
Macrophages/*metabolism
NF-kappa B/*metabolism
Polysaccharides/*pharmacology
CD4-Positive T-Lymphocytes/drug effects ; Cell Line ; Cell Movement/drug effects ; Chemokine CCL22/antagonists & inhibitors ; Chemokine CCL22/genetics ; Coculture Techniques ; Cytokines/genetics ; Humans ; Macrophages/drug effects ; Metabolic Networks and Pathways/drug effects ; Molecular Targeted Therapy/methods ; Phosphorylation/drug effects ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Anti-Inflammatory Effects of Ellagic Acid on Keratinocytes via MAPK and STAT Pathways.
Autorzy:: Gil TY; Department of Pharmacology, College of Korean Medicine, Sangji University, Wonju-si 26339, Gangwon-do, Korea.
Hong CH; Department of Korean Meidicne Ophthalmology & Otolaryngology & Dermatology, College of Korean Medicine, Sangji University, Wonju-si 26339, Gangwon-do, Korea.
An HJ; Department of Pharmacology, College of Korean Medicine, Sangji University, Wonju-si 26339, Gangwon-do, Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jan 28; Vol. 22 (3). Date of Electronic Publication: 2021 Jan 28.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Inflammatory Agents/*pharmacology
Dermatitis, Atopic/*drug therapy
Dermatophagoides farinae/*chemistry
Ellagic Acid/*pharmacology
Mitogen-Activated Protein Kinases/*genetics
STAT1 Transcription Factor/*genetics
STAT3 Transcription Factor/*genetics
Animals ; Antigens, Dermatophagoides/administration & dosage ; Chemokine CCL17/genetics ; Chemokine CCL17/immunology ; Chemokine CCL22/genetics ; Chemokine CCL22/immunology ; Chemokine CCL5/genetics ; Chemokine CCL5/immunology ; Complex Mixtures/administration & dosage ; Cytokines/genetics ; Cytokines/immunology ; Dermatitis, Atopic/chemically induced ; Dermatitis, Atopic/genetics ; Dermatitis, Atopic/immunology ; Dermatophagoides farinae/immunology ; Disease Models, Animal ; Female ; Gene Expression Regulation ; HaCaT Cells ; Humans ; Interferon-gamma/antagonists & inhibitors ; Interferon-gamma/pharmacology ; Mice ; Mitogen-Activated Protein Kinases/immunology ; STAT1 Transcription Factor/immunology ; STAT3 Transcription Factor/immunology ; Signal Transduction ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/pharmacology ; Thymic Stromal Lymphopoietin

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumab.
Autorzy:: Ohuchi K; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Fujimura T; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Lyu C; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Amagai R; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Muto Y; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Aiba S; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Pokaż więcej
Źródło:: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14099. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, T-Cell, Cutaneous*
Mycosis Fungoides*/drug therapy
Skin Neoplasms*/drug therapy
Antibodies, Monoclonal, Humanized ; Chemokine CCL17 ; Chemokine CCL22 ; Humans ; Receptors, CCR4

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal Inflammation.
Autorzy:: Niven J; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom; Division of Rheumatology and Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
Hoare J; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom.
McGowan D; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom.
Devarajan G; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom.
Itohara S; RIKEN Brain Science Institute, Wako, Japan.
Gannagé M; Division of Rheumatology and Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
Teismann P; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom.
Crane I; Division of Applied Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Jul 23; Vol. 10 (7), pp. e0132688. Date of Electronic Publication: 2015 Jul 23 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Chemokine CCL22/*genetics
Interleukin-1beta/*genetics
Macrophages/*immunology
Retinitis/*genetics
S100 Calcium Binding Protein beta Subunit/*metabolism
Uveitis/*genetics
Animals ; Cell Line ; Chemokine CCL22/metabolism ; Disease Models, Animal ; Gene Expression Regulation ; Interleukin-1beta/metabolism ; Macrophages/pathology ; Mice ; Mice, Knockout ; Retinitis/metabolism ; Retinitis/pathology ; S100 Calcium Binding Protein beta Subunit/genetics ; Uveitis/metabolism ; Uveitis/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.
Autorzy:: Mäntylä T; Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland; Brain Research Unit, O.V. Lounasmaa Laboratory and Advanced Magnetic Imaging Centre, Aalto NeuroImaging, Aalto University School of Science, Espoo, Finland; Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland.
Mantere O; Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland; Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland; Institute of Clinical Medicine, Department of Psychiatry, Helsinki University, Helsinki, Finland.
Raij TT; Brain Research Unit, O.V. Lounasmaa Laboratory and Advanced Magnetic Imaging Centre, Aalto NeuroImaging, Aalto University School of Science, Espoo, Finland; Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland.
Kieseppä T; Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland; Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland.
Laitinen H; Vaccination Programme Unit, National Institute for Health and Welfare, Helsinki, Finland.
Leiviskä J; Genomics and Biomarkers Unit, National Institute for Health and Welfare, Helsinki, Finland.
Torniainen M; Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Tuominen L; Turku PET centre, University of Turku, Turku, Finland; Department of Psychiatry, University of Turku, Turku, Finland.
Vaarala O; Respiratory, Inflammatory and Autoimmunity, Innovative Medicine, AstraZeneca R & D, Mölndal, Sweden; Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland.
Suvisaari J; Mental Health Unit, National Institute for Health and Welfare, Helsinki, Finland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 May 13; Vol. 10 (5), pp. e0125112. Date of Electronic Publication: 2015 May 13 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Immunity, Innate*
Apolipoprotein A-I/*immunology
Chemokine CCL22/*immunology
Frontal Lobe/*immunology
Psychotic Disorders/*immunology
White Matter/*immunology
Adolescent ; Adult ; Anisotropy ; Antipsychotic Agents/therapeutic use ; Apolipoprotein A-I/blood ; Case-Control Studies ; Chemokine CCL22/blood ; Chemokine CCL7/blood ; Chemokine CCL7/immunology ; Chemokine CXCL1/blood ; Chemokine CXCL1/immunology ; Diffusion Magnetic Resonance Imaging ; Diffusion Tensor Imaging ; Female ; Frontal Lobe/metabolism ; Frontal Lobe/pathology ; Gene Expression/immunology ; Gray Matter/immunology ; Gray Matter/metabolism ; Gray Matter/pathology ; Humans ; Image Processing, Computer-Assisted ; Interferon-alpha/blood ; Interferon-alpha/immunology ; Male ; Psychotic Disorders/blood ; Psychotic Disorders/drug therapy ; Psychotic Disorders/pathology ; Transforming Growth Factor alpha/blood ; Transforming Growth Factor alpha/immunology ; White Matter/metabolism ; White Matter/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Can moderate-intensity aerobic exercise ameliorate atopic dermatitis?
Autorzy:: Son WK; Allergy Immunology Center, Korea University, Seoul, Korea.; Department of Physical Education, Korea University College of Education, Seoul, Korea.
Yoon W; Allergy Immunology Center, Korea University, Seoul, Korea.
Kim S; Allergy Immunology Center, Korea University, Seoul, Korea.
Byeon JH; Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
Lee JS; Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
Kim D; Allergy Immunology Center, Korea University, Seoul, Korea.
Jaehoon L; Allergy Immunology Center, Korea University, Seoul, Korea.
Chae Y; Department of Pathology, Korea University College of Medicine, Seoul, Korea.
Yoon SJ; Department of Physical Education, Korea University College of Education, Seoul, Korea.
Yoo Y; Allergy Immunology Center, Korea University, Seoul, Korea.; Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Experimental dermatology [Exp Dermatol] 2020 Aug; Vol. 29 (8), pp. 699-702. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cytokines/*blood
Dermatitis, Atopic/*therapy
Eczema/*immunology
Eczema/*therapy
Physical Conditioning, Animal/*physiology
Animals ; Chemokine CCL2/blood ; Chemokine CCL22/blood ; Dermatitis, Atopic/immunology ; Dinitrochlorobenzene ; Eczema/blood ; Eczema/chemically induced ; Female ; Immunoglobulin E/blood ; Mice ; Physical Conditioning, Animal/methods ; Severity of Illness Index

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity.
Autorzy:: Lewis CV; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.
Vinh A; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.; Department of Physiology, Anatomy & Microbiology, School of Life Sciences, La Trobe University, VIC 3086, Australia.
Diep H; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.; Department of Physiology, Anatomy & Microbiology, School of Life Sciences, La Trobe University, VIC 3086, Australia.
Samuel CS; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.
Drummond GR; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.; Department of Physiology, Anatomy & Microbiology, School of Life Sciences, La Trobe University, VIC 3086, Australia.
Kemp-Harper BK; Cardiovascular Disease Program, Biomedicine Discovery Institute & Department of Pharmacology, Monash University, VIC 3800, Australia.; Pokaż więcej
Źródło:: Journal of immunology research [J Immunol Res] 2019 Nov 11; Vol. 2019, pp. 1278301. Date of Electronic Publication: 2019 Nov 11 (Print Publication: 2019).
Typ publikacji:: Journal Article
MeSH Terms:: Fibroblasts/*drug effects
Interferon-gamma/*pharmacology
Interleukin-4/*pharmacology
Lipopolysaccharides/*pharmacology
Macrophages/*drug effects
Signal Transduction/*genetics
Catalase/pharmacology ; Chemokine CCL22/genetics ; Chemokine CCL22/immunology ; Chemokine CXCL11/genetics ; Chemokine CXCL11/immunology ; Chemokines, CC/genetics ; Chemokines, CC/immunology ; Coculture Techniques ; Collagen Type I/genetics ; Collagen Type I/immunology ; Fibroblasts/cytology ; Fibroblasts/immunology ; Gene Expression Regulation ; Humans ; Hydrogen Peroxide/metabolism ; Interferon-gamma/antagonists & inhibitors ; Interleukin-1beta/genetics ; Interleukin-1beta/immunology ; Interleukin-4/antagonists & inhibitors ; Lipopolysaccharides/antagonists & inhibitors ; Macrophage Activation/drug effects ; Macrophages/cytology ; Macrophages/immunology ; Membrane Glycoproteins/genetics ; Membrane Glycoproteins/immunology ; NADPH Oxidase 2/genetics ; NADPH Oxidase 2/immunology ; Oxidation-Reduction/drug effects ; Polyethylene Glycols/pharmacology ; Primary Cell Culture ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Receptors, CCR7/genetics ; Receptors, CCR7/immunology ; Receptors, Immunologic/genetics ; Receptors, Immunologic/immunology ; Superoxides/metabolism ; THP-1 Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Chemokine CCL22"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język